Jb. Weinberg et al., COBALAMIN INHIBITION OF HIV-1 INTEGRASE AND INTEGRATION OF HIV-1 DNA INTO CELLULAR DNA, Biochemical and biophysical research communications, 246(2), 1998, pp. 393-397
Our prior studies showed that certain cobalamins inhibit productive HI
V-1 infection of primary cultures of blood lymphocytes and monocytes.
We demonstrate here that this antiviral activity may be mediated by an
inhibition of HIV-1 integrase, an enzyme required for productive infe
ction. Purified recombinant HIV-1 integrase activity was inhibited in
vitro by hydroxocobalamin (OH-Cbl), methylcobalamin (Me-Cbl), adenosyl
cobalamin (Ado-Cbl), and dicyanocobinamide (CN(2)Cbi) with IC50 values
of approximately 17, 17, 17, and 4 mu M, respectively. The agents inh
ibited HIV-1 infection of cultured monocytes (IC50 values for OH-Cbl,
Me-Cbl, Ado-Cbl, and CN2-Cbi of 6, 7, 4, and 1 mu M, respectively) and
of cultured lymphocytes (IC50 values of 60, 50, 60, and 11 mu M, resp
ectively). Experiments using cultured monocytes or lymphocytes demonst
rated that OH-Cbl inhibited integration of HIV-1 DNA into cellular DNA
. Thus, cobalamins and cobinamides represent novel inhibitors of HIV-1
integrase. These or related agents may be useful as anti-viral treatm
ents that target HIV-1 integrase. (C) 1998 Academic Press.